Gino Cortopassi has been studying mitochondrial and metabolic contributions to aging and longevity since 1990, demonstrating decay of mitochondrial genomes in the brain and other less mitotic tissues. He has investigated the healthy aging benefits of genetic Shc depletion and possible pharmacologic Shc inhibitors, and the benefits of activating mitochondrial function to delay age-related losses of function.